NCT06328062View on ClinicalTrials.gov

Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Pain PostoperativeOsteoarthritisTotal Knee Arthroplasty
Interventions
DRUG

Mirogabalin

Participants will receive 5 mg of mirogabalin, taken as half a tablet, every day twice a day, after breakfast and dinner, for 6 weeks.

DRUG

Pregabalin

Participants will receive 50 mg of pregabalin, taken as a tablet, every day twice a day, after breakfast and dinner, for 6 weeks.

Trial Locations (1)

12120

RECRUITING

Thammasat University Hospital, Khlong Luang

All Listed Sponsors
lead

Thammasat University Hospital

OTHER